Reneo Pharmaceuticals (RPHM)
NASDAQ:RPHM
US Market
Holding RPHM?
Track your performance easily

Reneo Pharmaceuticals (RPHM) Financial Statements

238 Followers

Reneo Pharmaceuticals Financial Overview

Reneo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-16.851; its P/E ratio is -1.11; Reneo Pharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.36M$ -9.56M$ -20.89M$ -19.53M$ -15.11M
EBITDA$ -4.44M$ -9.55M$ -20.84M$ -20.61M$ -15.72M
Net Income Common Stockholders$ -5.36M$ -8.43M$ -19.20M$ -19.50M$ -15.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 76.67M$ 82.83M$ 125.61M$ 142.68M$ 93.79M
Total Assets$ 78.72M$ 84.64M$ 130.39M$ 148.04M$ 98.29M
Total Debt$ 823.00K$ 907.00K$ 1.14M$ 1.22M$ 1.34M
Net Debt$ -75.85M$ -81.93M$ -124.48M$ -141.46M$ -92.44M
Total Liabilities$ 1.85M$ 3.40M$ 15.44M$ 15.51M$ 11.78M
Stockholders Equity$ 76.87M$ 81.24M$ 114.94M$ 132.53M$ 87.08M
Cash Flow-
Free Cash Flow$ -6.81M$ -21.01M$ -18.79M$ -16.12M$ -9.22M
Operating Cash Flow$ -6.81M$ -21.01M$ -18.77M$ -16.11M$ -9.05M
Investing Cash Flow$ 22.49M$ 13.76M$ 21.25M$ -69.01M$ 18.51M
Financing Cash Flow$ -89.00K-$ 173.00K$ 63.81M$ 1.01M
Currency in USD

Reneo Pharmaceuticals Earnings and Revenue History

Reneo Pharmaceuticals Debt to Assets

Reneo Pharmaceuticals Cash Flow

Reneo Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis